1,4-dicarboxybenzene mono-4-methoxybenzyl ester | 86208-24-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1,4-dicarboxybenzene mono-4-methoxybenzyl ester
• 英文别名: 4-[(4-Methoxyphenyl)methoxycarbonyl]benzoic acid
• CAS: 86208-24-4
• 化学式: C₁₆H₁₄O₅
• 分子量: 286.284
• InChiKey: GKYANRMFJXCXPS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  21
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  72.8
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  1,4-dicarboxybenzene mono-4-methoxybenzyl ester 在 (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate 、 N,N-二异丙基乙胺 、 三氟乙酸 、 苯酚 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 7.0h， 生成 4-((1-(4-(5-chloro-2-(1H-tetrazol-1-yl)phenyl)-1H-1,2,3-triazol-1-yl)-3-phenylpropan-2-yl)carbamoyl)benzoic acid
  参考文献：
  名称：

  인자 ＸＩａ 억제 활성을 가지는 신규한 화합물

  摘要：

  This is the translation of the text you provided: This invention relates to a novel compound represented by the chemical formula 1 having pharmacologically effective amounts inhibiting the activity of Factor XIa (Factor XIa, FXIa), its preparation method, and pharmaceutical compositions for the prevention of blood coagulation and the treatment of various thrombotic disorders, comprising the compound as an active ingredient. In the chemical formula 1, A, L, X, Y, Z, and n are as defined in this specification.

  公开号：

  KR20150136294A
• 作为产物：
  描述：

  对苯二甲酸 、 4-甲氧基氯苄 在 二环己胺 、 sodium iodide 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 生成 1,4-dicarboxybenzene mono-4-methoxybenzyl ester
  参考文献：
  名称：

  Side chain specificity in the pnzymatic synthesis of eenicillins

  摘要：

  DOI：

  10.1016/s0040-4020(01)88393-9

文献信息

• Carboxylic beta-lactam compounds and the preparation thereof
  申请人：SUMITOMO PHARMACEUTICALS COMPANY, LIMITED

  公开号：EP0070204A2

  公开（公告）日：1983-01-19

  Penem compounds are of the formula: where R1 is H or 1-hydroxyethyl, wherein the -OH may be protected by a protecting group, e.g. alkoxycarbonyl, R2 is one of 21 aliphatic, aromatic or heterocyclic groups shown, and R3 is H or a protecting group for the -COO, e.g. alkyl. Preparative methods depend on the nature of R2 and include: (a) heating a compound of and optionally removing protecting groups. Methods are described of synthesing the compound (II) from a compound. The Compounds (1) are useful antibacterial compounds.

  青霉烯化合物的化学式如下 其中 R1 为 H 或 1-羟乙基，其中 -OH 可由保护基团（如烷氧羰基）保护、 R2 是所示 21 个脂肪族、芳香族或杂环族基团之一，以及 R3 是 H 或 -COO 的保护基团，如烷基。 制备方法取决于 R2 的性质，包括 (a) 加热 并选择性地去除保护基团。 描述了从化合物合成化合物 (II) 的方法。 化合物(1)是有用的抗菌化合物。
• BALDWIN, JACK E.;SCHOFIELD, CHRISTOPHER J.;SMITH, BRADLEY D., TETRAHEDRON, 46,(1990) N, C. 3019-3028
  作者：BALDWIN, JACK E.、SCHOFIELD, CHRISTOPHER J.、SMITH, BRADLEY D.

  DOI：——

  日期：——
• US4742052A
  申请人：——

  公开号：US4742052A

  公开（公告）日：1988-05-03
• 인자 ＸＩａ 억제 활성을 가지는 신규한 화합물
  申请人：LEGOCHEM BIOSCIENCES, INC. 주식회사 레고켐 바이오사이언스(120060498483) Corp. No ▼ 160111-0206866BRN ▼314-81-82268

  公开号：KR20150136294A

  公开（公告）日：2015-12-07

  본 발명은 인자 XIa (Factor XIa, FXIa)에 대해 억제 활성을 가지는 약리학적 유효량의 하기 화학식 1로 표시되는 신규한 화합물 및 이의 제조방법과, 이의 약제학적으로 허용되는 염, 수화물, 용매화물, 이성질체 및 프로드럭을 유효성분으로 함유하는 혈액 응고 예방 및 각종 혈전증의 치료를 위한 약제 조성물에 관한 것이다. (1) 상기 화학식 1에서, A, L, X, Y, Z 및 n은 본 명세서에 정의된 바와 동일하다.

  This is the translation of the text you provided: This invention relates to a novel compound represented by the chemical formula 1 having pharmacologically effective amounts inhibiting the activity of Factor XIa (Factor XIa, FXIa), its preparation method, and pharmaceutical compositions for the prevention of blood coagulation and the treatment of various thrombotic disorders, comprising the compound as an active ingredient. In the chemical formula 1, A, L, X, Y, Z, and n are as defined in this specification.
• Side chain specificity in the pnzymatic synthesis of eenicillins
  作者：Jack E. Baldwin、Christopher J. Schofield、Bradley D. Smith

  DOI：10.1016/s0040-4020(01)88393-9

  日期：1990.1